Variant report
Variant | nsv963166 |
---|---|
Chromosome Location | chr2:110424979-110429030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD57-2 | chr2:110425357-110425579 | NONHSAT073148 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534403414 | chr2:110424988-110424989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188952647 | chr2:110424989-110424990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574541392 | chr2:110425001-110425002 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143911907 | chr2:110425009-110425010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563249470 | chr2:110425043-110425044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs58705212 | chr2:110425057-110425058 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs545817975 | chr2:110425108-110425109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559468371 | chr2:110425125-110425126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4953764 | chr2:110425136-110425137 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs548385999 | chr2:110425157-110425158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562354601 | chr2:110425193-110425194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147279625 | chr2:110425280-110425281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529894319 | chr2:110425282-110425283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550713426 | chr2:110425292-110425293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551154504 | chr2:110425317-110425318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547691988 | chr2:110425365-110425366 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs540116108 | chr2:110425382-110425383 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs1036316 | chr2:110425390-110425391 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs7575793 | chr2:110425427-110425428 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs144977631 | chr2:110425467-110425468 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs146486089 | chr2:110425468-110425469 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs113740384 | chr2:110425470-110425471 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs3065964 | chr2:110425472-110425473 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs79898027 | chr2:110425473-110425474 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs386649138 | chr2:110425608-110425609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534760170 | chr2:110425609-110425610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78214157 | chr2:110425635-110425636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60422565 | chr2:110425641-110425642 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs191783627 | chr2:110425642-110425643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553289708 | chr2:110425656-110425657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140834736 | chr2:110425669-110425670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142258546 | chr2:110425696-110425697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573096305 | chr2:110425704-110425705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538823136 | chr2:110425716-110425717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576757529 | chr2:110425721-110425722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183995123 | chr2:110425731-110425732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189334527 | chr2:110425740-110425741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573153448 | chr2:110425751-110425752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542160386 | chr2:110425754-110425755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35727718 | chr2:110425831-110425832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150825611 | chr2:110425859-110425860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371053112 | chr2:110425923-110425924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375749011 | chr2:110425924-110425925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368198300 | chr2:110425927-110425928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115574182 | chr2:110425928-110425929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530993102 | chr2:110425957-110425958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544848363 | chr2:110425965-110425966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537125814 | chr2:110425978-110425979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544270849 | chr2:110425979-110425980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564654248 | chr2:110425980-110425981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 22495309 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
Autism | 22549408 | CNVD |
Autism | 21865298 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:110420400-110425000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:110421600-110425000 | Weak transcription | Esophagus | oesophagus |
3 | chr2:110421600-110438600 | Weak transcription | Right Atrium | heart |
4 | chr2:110422000-110426200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr2:110424200-110425000 | Enhancers | Aorta | Aorta |
6 | chr2:110424800-110425000 | Enhancers | Stomach Smooth Muscle | stomach |
7 | chr2:110424800-110425200 | Enhancers | Fetal Brain Male | brain |
8 | chr2:110424800-110425400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr2:110425000-110425200 | Enhancers | Esophagus | oesophagus |
10 | chr2:110425000-110425600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr2:110425400-110432400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr2:110425600-110429000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr2:110426200-110426800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr2:110427400-110429000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr2:110428200-110428400 | Enhancers | HepG2 | liver |
16 | chr2:110428400-110429000 | Flanking Active TSS | HepG2 | liver |
17 | chr2:110428800-110429000 | ZNF genes & repeats | Gastric | stomach |
18 | chr2:110429000-110429200 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
19 | chr2:110429000-110429200 | Enhancers | HepG2 | liver |
20 | chr2:110429000-110441200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |